Growth Factor Signature (GFS) Pilot Study (MK0000-098)(COMPLETED)

Clinical trial NCT00860535 · TERMINATED

Trial details

NCT number: NCT00860535
Sponsor: Merck Sharp & Dohme LLC
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Blast Phase Philadelphia Chromosomes Positive (Ph+) Chronic Myelogenous Leukemia (CML)Philadelphia Chromosome Positive (Ph+) Acute Lymphocytic Leukemia (ALL)

Start date: 2009-06-01
Primary completion: 2010-04-01
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.